Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125981502 | 12598150 | 2 | F | 20160720 | 20160726 | 20160729 | EXP | US-JNJFOC-20160716584 | JANSSEN | HALE GM, KANE-GILL SL, GROETZINGER L, SMITHBURGER PL. AN EVALUATION OF ADVERSE DRUG REACTIONS ASSOCIATED WITH ANTIPSYCHOTIC USE FOR THE TREATMENT OF DELIRIUM IN THE INTENSIVE CARE UNIT. JOURNAL OF PHARMACY PRACTICE 2016;29(4):355-360. | 0.00 | Y | 0.00000 | 20160729 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125981502 | 12598150 | 1 | PS | HALOPERIDOL. | HALOPERIDOL | 1 | Unknown | U | U | 15923 | UNSPECIFIED | ||||||||
125981502 | 12598150 | 2 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | U | U | 20272 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125981502 | 12598150 | 1 | Delirium |
125981502 | 12598150 | 2 | Delirium |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125981502 | 12598150 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125981502 | 12598150 | Electrocardiogram QT prolonged | |
125981502 | 12598150 | Neutropenia | |
125981502 | 12598150 | Pyrexia | |
125981502 | 12598150 | Somnolence | |
125981502 | 12598150 | Ventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |